These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 22217678

  • 1. Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single-dose nevirapine.
    Aizire J, McConnell MS, Mudiope P, Mubiru M, Matovu F, Parsons TL, Elbireer A, Nolan M, Janoff EN, Fowler MG.
    J Acquir Immune Defic Syndr; 2012 Aug 15; 60(5):483-8. PubMed ID: 22217678
    [Abstract] [Full Text] [Related]

  • 2. Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis.
    Salado-Rasmussen K, Theilgaard ZP, Chiduo MG, Bygbjerg IC, Gerstoft J, Lüneborg-Nielsen M, Lemnge M, Katzenstein TL.
    PLoS One; 2015 Aug 15; 10(3):e0121111. PubMed ID: 25812161
    [Abstract] [Full Text] [Related]

  • 3. Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.
    Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH.
    AIDS; 2010 Feb 20; 24(4):557-61. PubMed ID: 20057308
    [Abstract] [Full Text] [Related]

  • 4. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
    Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB.
    AIDS; 1999 Mar 11; 13(4):479-86. PubMed ID: 10197376
    [Abstract] [Full Text] [Related]

  • 5. Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.
    Kunz A, Frank M, Mugenyi K, Kabasinguzi R, Weidenhammer A, Kurowski M, Kloft C, Harms G.
    J Antimicrob Chemother; 2009 Jan 11; 63(1):170-7. PubMed ID: 18974161
    [Abstract] [Full Text] [Related]

  • 6. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC.
    Antivir Ther; 2008 Jan 11; 13(6):799-807. PubMed ID: 18839781
    [Abstract] [Full Text] [Related]

  • 7. Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.
    Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Jones SA, Mofenson LM, Contag CH, Bassett M, Katzenstein DA, HIVNET 023 Study Team.
    J Infect Dis; 2005 Oct 01; 192(7):1260-4. PubMed ID: 16136470
    [Abstract] [Full Text] [Related]

  • 8. Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children.
    Chaix ML, Ekouevi DK, Peytavin G, Rouet F, Tonwe-Gold B, Viho I, Bequet L, Amani-Bosse C, Menan H, Leroy V, Rouzioux C, Dabis F.
    Antimicrob Agents Chemother; 2007 Mar 01; 51(3):896-901. PubMed ID: 17178792
    [Abstract] [Full Text] [Related]

  • 9. Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
    Frank M, von Kleist M, Kunz A, Harms G, Schütte C, Kloft C.
    Antimicrob Agents Chemother; 2011 Dec 01; 55(12):5529-40. PubMed ID: 21947390
    [Abstract] [Full Text] [Related]

  • 10. Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
    Permar SR, Salazar MG, Gao F, Cai F, Learn GH, Kalilani L, Hahn BH, Shaw GM, Salazar-Gonzalez JF.
    Retrovirology; 2013 Aug 14; 10():88. PubMed ID: 23941304
    [Abstract] [Full Text] [Related]

  • 11. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 12. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
    Pilger D, Hauser A, Kuecherer C, Mugenyi K, Kabasinguzi R, Somogyi S, Harms G, Kunz A.
    Antivir Ther; 2011 Feb 15; 16(1):109-13. PubMed ID: 21311114
    [Abstract] [Full Text] [Related]

  • 13. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
    Lallemant M, Le Coeur S, Sirirungsi W, Cressey TR, Ngo-Giang-Huong N, Traisathit P, Klinbuayaem V, Sabsanong P, Kanjanavikai P, Jourdain G, Mcintosh K, Koetsawang S, PHPT-5 study investigators.
    AIDS; 2015 Nov 28; 29(18):2497-507. PubMed ID: 26372485
    [Abstract] [Full Text] [Related]

  • 14. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC.
    AIDS; 2005 Sep 02; 19(13):1415-22. PubMed ID: 16103773
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Njiri F, John-Stewart GC.
    J Acquir Immune Defic Syndr; 2007 Dec 01; 46(4):472-8. PubMed ID: 18077838
    [Abstract] [Full Text] [Related]

  • 17. Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.
    Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, Thakar M, Bharadwaj R, Kagal A, Bhore AV, Patil S, Kulkarni V, Venkataramani V, Balasubramaniam U, Suryavanshi N, Ziemniak C, Gupte N, Bollinger R, Persaud D.
    PLoS One; 2009 Dec 01; 4(1):e4096. PubMed ID: 19119321
    [Abstract] [Full Text] [Related]

  • 18. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
    Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, Eshleman SH.
    AIDS Res Hum Retroviruses; 2009 Jul 01; 25(7):673-7. PubMed ID: 19552593
    [Abstract] [Full Text] [Related]

  • 19. Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis.
    Anugulruengkitt S, Cressey TR, Suntarattiwong P, Ounchanum P, Srirompotong U, Jantarabenjakul W, Sophonphan J, Tawon Y, Punnahitanon S, Pancharoen C, Chokephaibulkit K, Puthanakit T, CIPHER_AEPEP Study Team.
    Pediatr Infect Dis J; 2019 Feb 01; 38(2):152-156. PubMed ID: 30204660
    [Abstract] [Full Text] [Related]

  • 20. Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
    Mugabo P, Els I, Smith J, Rabie H, Smith P, Mirochnick M, Steyn W, Hall D, Madsen R, Cotton MF.
    S Afr Med J; 2011 Sep 05; 101(9):655-8. PubMed ID: 21920159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.